Physician profile
David Schaeffer
NPI 1578679494
$3,542.72
in general payments reported to CMS, 2019-2025
14 companies · $37.15 in 2025
The $37.15 reported for 2025 was less than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,674 · 2020: $69.59 · 2021: $46.58 · 2022: $1,457 · 2023: $103 · 2024: $155 · 2025: $37.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pari Respiratory Equipment, INC. | $1,627.50 | 2019 | |
| Genzyme Corporation | $1,484.04 | 2021-2024 | |
| Glaxosmithkline, LLC. | $119.01 | 2023-2024 | Nucala |
| Gilead Sciences, INC. | $100.00 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $58.82 | 2019-2021 | |
| Philips North America LLC | $33.32 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $32.35 | 2023-2025 | Fasenra |
| Novartis Pharmaceuticals Corporation | $21.08 | 2020 | |
| Boston Scientific Corporation | $19.33 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $17.78 | 2025 | Dupixent |
| Circassia INC. | $15.44 | 2019 | |
| Abbvie INC. | $14.05 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schaeffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.